NCT01055873

Brief Summary

ANRS-EP38-IMMIP is a non interventional study. A single blood sample (30 mL) was drawn during a hospital visit for clinical follow-up. Immunological assays were performed on fresh blood. Cells and plasma were stored and kept frozen for additional biological evaluations. Patients are included in the French perinatal cohort (ANRS CO-10), or have been followed since before 1996 in the same clinical sites as patients who belong to ANRS CO-10. In the ANRS CO-10 cohort, all patients are prospectively followed from birth.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2007

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2009

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 24, 2009

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 26, 2010

Completed
Last Updated

November 18, 2010

Status Verified

November 1, 2010

Enrollment Period

2 years

First QC Date

December 24, 2009

Last Update Submit

November 17, 2010

Conditions

Keywords

immune statusadolescents or young adults infectedimpact of viral replication

Outcome Measures

Primary Outcomes (1)

  • To describe the immune and virological status of perinatally infected patients that are above 15 yrs old and

Secondary Outcomes (1)

  • To study their associations with the current virological/clinical and therapeutic status, the duration of uncontrolled viremia (defined by treatment history), the virological, immunological (CD4+ numbers), and clinical status

Interventions

A single blood sample (30 mL) was drawn during a hospital visit for clinical follow-up. Immunological assays were performed on fresh blood. Cells and plasma were stored and kept frozen for additional biological evaluations

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients are included in the French perinatal cohort (ANRS CO-10), or have been followed since before 1996 in the same clinical sites as patients who belong to ANRS CO-10. In the ANRS CO-10 cohort, all patients are prospectively followed from birth

You may qualify if:

  • Being included in the ANRS CO-10 cohort, or being followed in the same sites as such patients since before 1996
  • Being followed in the Paris area
  • HIV-1 infected through the perinatal route, and not HIV-2 co-infected
  • No therapeutic changes for at least 6 months; single molecule change without modification of viral load is tolerated.
  • Informed consent signed by the patients and by their legal guardians for those younger than 18.

You may not qualify if:

  • \- Not Being affiliated to the French national social security system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Avettand-Fenoel V, Blanche S, Le Chenadec J, Scott-Algara D, Dollfus C, Viard JP, Bouallag N, Benmebarek Y, Riviere Y, Warszawski J, Rouzioux C, Buseyne F. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. J Infect Dis. 2012 May 15;205(10):1520-8. doi: 10.1093/infdis/jis233. Epub 2012 Mar 15.

Related Links

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Warszawski MD Josiane, Methodologist

    INSERM U 822, Hôpital de Bicêtre, portes 10 à 15, 82 rue du Général Leclerc, 94276 Le Kremlin-Bicêtre Cedex warszaws@vjf.inserm.fr ; Tel : 01 45 21 22 86

    STUDY CHAIR
  • Blanche PHD Stéphane

    Hopital Necker Enfants malades-Service immunologie hématologie pédiatrique -149 rue de Sèvres- 75015 PARIS 01 44 49 48 24

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

December 24, 2009

First Posted

January 26, 2010

Study Start

February 1, 2007

Primary Completion

February 1, 2009

Study Completion

February 1, 2009

Last Updated

November 18, 2010

Record last verified: 2010-11